Global COX-2 Selective NSAIDs Market Growth 2026-2032
The global COX-2 Selective NSAIDs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have analgesic, antipyretic and anti-inflammatory effects, but can also cause a series of adverse reactions. Their mechanism of action is mainly to inhibit cyclooxygenase [cyclooxygenase, COX; also known as prostaglandin synthase (PGHS)], preventing the conversion of arachidonic acid into various prostaglandins, prostacyclins and thromboxanes. COX has two isoenzymes, COX-1 and COX-2, and there are significant differences in the regulation and expression of the two in different tissues. Various NSAIDs have different enzyme inhibition abilities, which can affect their activity and toxicity at the same time. Before the discovery of the COX-2 isoenzyme in the early 1990s, most NSAIDs could effectively inhibit both COXs. However, researchers later developed NSAIDs that can preferentially inhibit COX-2 while retaining the activity of COX-1. COX-2 is in the inflammatory mediators and participates in the production of inflammatory mediators, while COX-1 has an important gastric cell protective effect. The new drugs are called COX-2 selective NSAIDs (COXIBs), also known as COX-2 inhibitors and COX-2 selective inhibitors.
United States market for COX-2 Selective NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for COX-2 Selective NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for COX-2 Selective NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key COX-2 Selective NSAIDs players cover Pfizer, Teva, Mylan, Apotex, Lupin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?COX-2 Selective NSAIDs Industry Forecast? looks at past sales and reviews total world COX-2 Selective NSAIDs sales in 2025, providing a comprehensive analysis by region and market sector of projected COX-2 Selective NSAIDs sales for 2026 through 2032. With COX-2 Selective NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COX-2 Selective NSAIDs industry.
This Insight Report provides a comprehensive analysis of the global COX-2 Selective NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COX-2 Selective NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global COX-2 Selective NSAIDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COX-2 Selective NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COX-2 Selective NSAIDs.
This report presents a comprehensive overview, market shares, and growth opportunities of COX-2 Selective NSAIDs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global COX-2 Selective NSAIDs market?
What factors are driving COX-2 Selective NSAIDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do COX-2 Selective NSAIDs market opportunities vary by end market size?
How does COX-2 Selective NSAIDs break out by Type, by Application?
Nonsteroidal anti-inflammatory drugs (NSAIDs) have analgesic, antipyretic and anti-inflammatory effects, but can also cause a series of adverse reactions. Their mechanism of action is mainly to inhibit cyclooxygenase [cyclooxygenase, COX; also known as prostaglandin synthase (PGHS)], preventing the conversion of arachidonic acid into various prostaglandins, prostacyclins and thromboxanes. COX has two isoenzymes, COX-1 and COX-2, and there are significant differences in the regulation and expression of the two in different tissues. Various NSAIDs have different enzyme inhibition abilities, which can affect their activity and toxicity at the same time. Before the discovery of the COX-2 isoenzyme in the early 1990s, most NSAIDs could effectively inhibit both COXs. However, researchers later developed NSAIDs that can preferentially inhibit COX-2 while retaining the activity of COX-1. COX-2 is in the inflammatory mediators and participates in the production of inflammatory mediators, while COX-1 has an important gastric cell protective effect. The new drugs are called COX-2 selective NSAIDs (COXIBs), also known as COX-2 inhibitors and COX-2 selective inhibitors.
United States market for COX-2 Selective NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for COX-2 Selective NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for COX-2 Selective NSAIDs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key COX-2 Selective NSAIDs players cover Pfizer, Teva, Mylan, Apotex, Lupin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?COX-2 Selective NSAIDs Industry Forecast? looks at past sales and reviews total world COX-2 Selective NSAIDs sales in 2025, providing a comprehensive analysis by region and market sector of projected COX-2 Selective NSAIDs sales for 2026 through 2032. With COX-2 Selective NSAIDs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world COX-2 Selective NSAIDs industry.
This Insight Report provides a comprehensive analysis of the global COX-2 Selective NSAIDs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on COX-2 Selective NSAIDs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global COX-2 Selective NSAIDs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for COX-2 Selective NSAIDs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global COX-2 Selective NSAIDs.
This report presents a comprehensive overview, market shares, and growth opportunities of COX-2 Selective NSAIDs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Celecoxib
- Rofecoxib
- Valdecoxib
- Etoricoxib
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Teva
- Mylan
- Apotex
- Lupin
- Jiangsu Hengrui Medicine
- Merck
What is the 10-year outlook for the global COX-2 Selective NSAIDs market?
What factors are driving COX-2 Selective NSAIDs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do COX-2 Selective NSAIDs market opportunities vary by end market size?
How does COX-2 Selective NSAIDs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global COX-2 Selective NSAIDs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for COX-2 Selective NSAIDs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for COX-2 Selective NSAIDs by Country/Region, 2021, 2025 & 2032
2.2 COX-2 Selective NSAIDs Segment by Type
2.2.1 Celecoxib
2.2.2 Rofecoxib
2.2.3 Valdecoxib
2.2.4 Etoricoxib
2.2.5 COX-2 Selective NSAIDs Sales by Type
2.2.5.1 Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
2.2.5.2 Global COX-2 Selective NSAIDs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global COX-2 Selective NSAIDs Sale Price by Type (2021-2026)
2.3 COX-2 Selective NSAIDs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 COX-2 Selective NSAIDs Sales by Application
2.3.4.1 Global COX-2 Selective NSAIDs Sale Market Share by Application (2021-2026)
2.3.4.2 Global COX-2 Selective NSAIDs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global COX-2 Selective NSAIDs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global COX-2 Selective NSAIDs Breakdown Data by Company
3.1.1 Global COX-2 Selective NSAIDs Annual Sales by Company (2021-2026)
3.1.2 Global COX-2 Selective NSAIDs Sales Market Share by Company (2021-2026)
3.2 Global COX-2 Selective NSAIDs Annual Revenue by Company (2021-2026)
3.2.1 Global COX-2 Selective NSAIDs Revenue by Company (2021-2026)
3.2.2 Global COX-2 Selective NSAIDs Revenue Market Share by Company (2021-2026)
3.3 Global COX-2 Selective NSAIDs Sale Price by Company
3.4 Key Manufacturers COX-2 Selective NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers COX-2 Selective NSAIDs Product Location Distribution
3.4.2 Players COX-2 Selective NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COX-2 SELECTIVE NSAIDS BY GEOGRAPHIC REGION
4.1 World Historic COX-2 Selective NSAIDs Market Size by Geographic Region (2021-2026)
4.1.1 Global COX-2 Selective NSAIDs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global COX-2 Selective NSAIDs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic COX-2 Selective NSAIDs Market Size by Country/Region (2021-2026)
4.2.1 Global COX-2 Selective NSAIDs Annual Sales by Country/Region (2021-2026)
4.2.2 Global COX-2 Selective NSAIDs Annual Revenue by Country/Region (2021-2026)
4.3 Americas COX-2 Selective NSAIDs Sales Growth
4.4 APAC COX-2 Selective NSAIDs Sales Growth
4.5 Europe COX-2 Selective NSAIDs Sales Growth
4.6 Middle East & Africa COX-2 Selective NSAIDs Sales Growth
5 AMERICAS
5.1 Americas COX-2 Selective NSAIDs Sales by Country
5.1.1 Americas COX-2 Selective NSAIDs Sales by Country (2021-2026)
5.1.2 Americas COX-2 Selective NSAIDs Revenue by Country (2021-2026)
5.2 Americas COX-2 Selective NSAIDs Sales by Type (2021-2026)
5.3 Americas COX-2 Selective NSAIDs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC COX-2 Selective NSAIDs Sales by Region
6.1.1 APAC COX-2 Selective NSAIDs Sales by Region (2021-2026)
6.1.2 APAC COX-2 Selective NSAIDs Revenue by Region (2021-2026)
6.2 APAC COX-2 Selective NSAIDs Sales by Type (2021-2026)
6.3 APAC COX-2 Selective NSAIDs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe COX-2 Selective NSAIDs by Country
7.1.1 Europe COX-2 Selective NSAIDs Sales by Country (2021-2026)
7.1.2 Europe COX-2 Selective NSAIDs Revenue by Country (2021-2026)
7.2 Europe COX-2 Selective NSAIDs Sales by Type (2021-2026)
7.3 Europe COX-2 Selective NSAIDs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa COX-2 Selective NSAIDs by Country
8.1.1 Middle East & Africa COX-2 Selective NSAIDs Sales by Country (2021-2026)
8.1.2 Middle East & Africa COX-2 Selective NSAIDs Revenue by Country (2021-2026)
8.2 Middle East & Africa COX-2 Selective NSAIDs Sales by Type (2021-2026)
8.3 Middle East & Africa COX-2 Selective NSAIDs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of COX-2 Selective NSAIDs
10.3 Manufacturing Process Analysis of COX-2 Selective NSAIDs
10.4 Industry Chain Structure of COX-2 Selective NSAIDs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 COX-2 Selective NSAIDs Distributors
11.3 COX-2 Selective NSAIDs Customer
12 WORLD FORECAST REVIEW FOR COX-2 SELECTIVE NSAIDS BY GEOGRAPHIC REGION
12.1 Global COX-2 Selective NSAIDs Market Size Forecast by Region
12.1.1 Global COX-2 Selective NSAIDs Forecast by Region (2027-2032)
12.1.2 Global COX-2 Selective NSAIDs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global COX-2 Selective NSAIDs Forecast by Type (2027-2032)
12.7 Global COX-2 Selective NSAIDs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer COX-2 Selective NSAIDs Product Portfolios and Specifications
13.1.3 Pfizer COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva COX-2 Selective NSAIDs Product Portfolios and Specifications
13.2.3 Teva COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan COX-2 Selective NSAIDs Product Portfolios and Specifications
13.3.3 Mylan COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex COX-2 Selective NSAIDs Product Portfolios and Specifications
13.4.3 Apotex COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin COX-2 Selective NSAIDs Product Portfolios and Specifications
13.5.3 Lupin COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Jiangsu Hengrui Medicine
13.6.1 Jiangsu Hengrui Medicine Company Information
13.6.2 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolios and Specifications
13.6.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangsu Hengrui Medicine Main Business Overview
13.6.5 Jiangsu Hengrui Medicine Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck COX-2 Selective NSAIDs Product Portfolios and Specifications
13.7.3 Merck COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global COX-2 Selective NSAIDs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for COX-2 Selective NSAIDs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for COX-2 Selective NSAIDs by Country/Region, 2021, 2025 & 2032
2.2 COX-2 Selective NSAIDs Segment by Type
2.2.1 Celecoxib
2.2.2 Rofecoxib
2.2.3 Valdecoxib
2.2.4 Etoricoxib
2.2.5 COX-2 Selective NSAIDs Sales by Type
2.2.5.1 Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
2.2.5.2 Global COX-2 Selective NSAIDs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global COX-2 Selective NSAIDs Sale Price by Type (2021-2026)
2.3 COX-2 Selective NSAIDs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 COX-2 Selective NSAIDs Sales by Application
2.3.4.1 Global COX-2 Selective NSAIDs Sale Market Share by Application (2021-2026)
2.3.4.2 Global COX-2 Selective NSAIDs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global COX-2 Selective NSAIDs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global COX-2 Selective NSAIDs Breakdown Data by Company
3.1.1 Global COX-2 Selective NSAIDs Annual Sales by Company (2021-2026)
3.1.2 Global COX-2 Selective NSAIDs Sales Market Share by Company (2021-2026)
3.2 Global COX-2 Selective NSAIDs Annual Revenue by Company (2021-2026)
3.2.1 Global COX-2 Selective NSAIDs Revenue by Company (2021-2026)
3.2.2 Global COX-2 Selective NSAIDs Revenue Market Share by Company (2021-2026)
3.3 Global COX-2 Selective NSAIDs Sale Price by Company
3.4 Key Manufacturers COX-2 Selective NSAIDs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers COX-2 Selective NSAIDs Product Location Distribution
3.4.2 Players COX-2 Selective NSAIDs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR COX-2 SELECTIVE NSAIDS BY GEOGRAPHIC REGION
4.1 World Historic COX-2 Selective NSAIDs Market Size by Geographic Region (2021-2026)
4.1.1 Global COX-2 Selective NSAIDs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global COX-2 Selective NSAIDs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic COX-2 Selective NSAIDs Market Size by Country/Region (2021-2026)
4.2.1 Global COX-2 Selective NSAIDs Annual Sales by Country/Region (2021-2026)
4.2.2 Global COX-2 Selective NSAIDs Annual Revenue by Country/Region (2021-2026)
4.3 Americas COX-2 Selective NSAIDs Sales Growth
4.4 APAC COX-2 Selective NSAIDs Sales Growth
4.5 Europe COX-2 Selective NSAIDs Sales Growth
4.6 Middle East & Africa COX-2 Selective NSAIDs Sales Growth
5 AMERICAS
5.1 Americas COX-2 Selective NSAIDs Sales by Country
5.1.1 Americas COX-2 Selective NSAIDs Sales by Country (2021-2026)
5.1.2 Americas COX-2 Selective NSAIDs Revenue by Country (2021-2026)
5.2 Americas COX-2 Selective NSAIDs Sales by Type (2021-2026)
5.3 Americas COX-2 Selective NSAIDs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC COX-2 Selective NSAIDs Sales by Region
6.1.1 APAC COX-2 Selective NSAIDs Sales by Region (2021-2026)
6.1.2 APAC COX-2 Selective NSAIDs Revenue by Region (2021-2026)
6.2 APAC COX-2 Selective NSAIDs Sales by Type (2021-2026)
6.3 APAC COX-2 Selective NSAIDs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe COX-2 Selective NSAIDs by Country
7.1.1 Europe COX-2 Selective NSAIDs Sales by Country (2021-2026)
7.1.2 Europe COX-2 Selective NSAIDs Revenue by Country (2021-2026)
7.2 Europe COX-2 Selective NSAIDs Sales by Type (2021-2026)
7.3 Europe COX-2 Selective NSAIDs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa COX-2 Selective NSAIDs by Country
8.1.1 Middle East & Africa COX-2 Selective NSAIDs Sales by Country (2021-2026)
8.1.2 Middle East & Africa COX-2 Selective NSAIDs Revenue by Country (2021-2026)
8.2 Middle East & Africa COX-2 Selective NSAIDs Sales by Type (2021-2026)
8.3 Middle East & Africa COX-2 Selective NSAIDs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of COX-2 Selective NSAIDs
10.3 Manufacturing Process Analysis of COX-2 Selective NSAIDs
10.4 Industry Chain Structure of COX-2 Selective NSAIDs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 COX-2 Selective NSAIDs Distributors
11.3 COX-2 Selective NSAIDs Customer
12 WORLD FORECAST REVIEW FOR COX-2 SELECTIVE NSAIDS BY GEOGRAPHIC REGION
12.1 Global COX-2 Selective NSAIDs Market Size Forecast by Region
12.1.1 Global COX-2 Selective NSAIDs Forecast by Region (2027-2032)
12.1.2 Global COX-2 Selective NSAIDs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global COX-2 Selective NSAIDs Forecast by Type (2027-2032)
12.7 Global COX-2 Selective NSAIDs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer COX-2 Selective NSAIDs Product Portfolios and Specifications
13.1.3 Pfizer COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva COX-2 Selective NSAIDs Product Portfolios and Specifications
13.2.3 Teva COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan COX-2 Selective NSAIDs Product Portfolios and Specifications
13.3.3 Mylan COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Apotex
13.4.1 Apotex Company Information
13.4.2 Apotex COX-2 Selective NSAIDs Product Portfolios and Specifications
13.4.3 Apotex COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Apotex Main Business Overview
13.4.5 Apotex Latest Developments
13.5 Lupin
13.5.1 Lupin Company Information
13.5.2 Lupin COX-2 Selective NSAIDs Product Portfolios and Specifications
13.5.3 Lupin COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Lupin Main Business Overview
13.5.5 Lupin Latest Developments
13.6 Jiangsu Hengrui Medicine
13.6.1 Jiangsu Hengrui Medicine Company Information
13.6.2 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolios and Specifications
13.6.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Jiangsu Hengrui Medicine Main Business Overview
13.6.5 Jiangsu Hengrui Medicine Latest Developments
13.7 Merck
13.7.1 Merck Company Information
13.7.2 Merck COX-2 Selective NSAIDs Product Portfolios and Specifications
13.7.3 Merck COX-2 Selective NSAIDs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Merck Main Business Overview
13.7.5 Merck Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. COX-2 Selective NSAIDs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. COX-2 Selective NSAIDs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Celecoxib
Table 4. Major Players of Rofecoxib
Table 5. Major Players of Valdecoxib
Table 6. Major Players of Etoricoxib
Table 7. Global COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 8. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Table 9. Global COX-2 Selective NSAIDs Revenue by Type (2021-2026) & ($ million)
Table 10. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2026)
Table 11. Global COX-2 Selective NSAIDs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global COX-2 Selective NSAIDs Sale by Application (2021-2026) & (K Units)
Table 13. Global COX-2 Selective NSAIDs Sale Market Share by Application (2021-2026)
Table 14. Global COX-2 Selective NSAIDs Revenue by Application (2021-2026) & ($ million)
Table 15. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2026)
Table 16. Global COX-2 Selective NSAIDs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global COX-2 Selective NSAIDs Sales by Company (2021-2026) & (K Units)
Table 18. Global COX-2 Selective NSAIDs Sales Market Share by Company (2021-2026)
Table 19. Global COX-2 Selective NSAIDs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global COX-2 Selective NSAIDs Revenue Market Share by Company (2021-2026)
Table 21. Global COX-2 Selective NSAIDs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers COX-2 Selective NSAIDs Producing Area Distribution and Sales Area
Table 23. Players COX-2 Selective NSAIDs Products Offered
Table 24. COX-2 Selective NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global COX-2 Selective NSAIDs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global COX-2 Selective NSAIDs Sales Market Share Geographic Region (2021-2026)
Table 29. Global COX-2 Selective NSAIDs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global COX-2 Selective NSAIDs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global COX-2 Selective NSAIDs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global COX-2 Selective NSAIDs Sales Market Share by Country/Region (2021-2026)
Table 33. Global COX-2 Selective NSAIDs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global COX-2 Selective NSAIDs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units)
Table 36. Americas COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026)
Table 37. Americas COX-2 Selective NSAIDs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 39. Americas COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 40. APAC COX-2 Selective NSAIDs Sales by Region (2021-2026) & (K Units)
Table 41. APAC COX-2 Selective NSAIDs Sales Market Share by Region (2021-2026)
Table 42. APAC COX-2 Selective NSAIDs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 44. APAC COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 45. Europe COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units)
Table 46. Europe COX-2 Selective NSAIDs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 48. Europe COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa COX-2 Selective NSAIDs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of COX-2 Selective NSAIDs
Table 54. Key Market Challenges & Risks of COX-2 Selective NSAIDs
Table 55. Key Industry Trends of COX-2 Selective NSAIDs
Table 56. COX-2 Selective NSAIDs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. COX-2 Selective NSAIDs Distributors List
Table 59. COX-2 Selective NSAIDs Customer List
Table 60. Global COX-2 Selective NSAIDs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global COX-2 Selective NSAIDs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas COX-2 Selective NSAIDs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC COX-2 Selective NSAIDs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC COX-2 Selective NSAIDs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe COX-2 Selective NSAIDs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa COX-2 Selective NSAIDs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global COX-2 Selective NSAIDs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global COX-2 Selective NSAIDs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global COX-2 Selective NSAIDs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global COX-2 Selective NSAIDs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 76. Pfizer COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Teva Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 81. Teva COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Mylan Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 86. Mylan COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Apotex Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 90. Apotex COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 91. Apotex COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Apotex Main Business
Table 93. Apotex Latest Developments
Table 94. Lupin Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 95. Lupin COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 96. Lupin COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Lupin Main Business
Table 98. Lupin Latest Developments
Table 99. Jiangsu Hengrui Medicine Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 100. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 101. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Jiangsu Hengrui Medicine Main Business
Table 103. Jiangsu Hengrui Medicine Latest Developments
Table 104. Merck Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 106. Merck COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
Table 1. COX-2 Selective NSAIDs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. COX-2 Selective NSAIDs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Celecoxib
Table 4. Major Players of Rofecoxib
Table 5. Major Players of Valdecoxib
Table 6. Major Players of Etoricoxib
Table 7. Global COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 8. Global COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Table 9. Global COX-2 Selective NSAIDs Revenue by Type (2021-2026) & ($ million)
Table 10. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2026)
Table 11. Global COX-2 Selective NSAIDs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global COX-2 Selective NSAIDs Sale by Application (2021-2026) & (K Units)
Table 13. Global COX-2 Selective NSAIDs Sale Market Share by Application (2021-2026)
Table 14. Global COX-2 Selective NSAIDs Revenue by Application (2021-2026) & ($ million)
Table 15. Global COX-2 Selective NSAIDs Revenue Market Share by Application (2021-2026)
Table 16. Global COX-2 Selective NSAIDs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global COX-2 Selective NSAIDs Sales by Company (2021-2026) & (K Units)
Table 18. Global COX-2 Selective NSAIDs Sales Market Share by Company (2021-2026)
Table 19. Global COX-2 Selective NSAIDs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global COX-2 Selective NSAIDs Revenue Market Share by Company (2021-2026)
Table 21. Global COX-2 Selective NSAIDs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers COX-2 Selective NSAIDs Producing Area Distribution and Sales Area
Table 23. Players COX-2 Selective NSAIDs Products Offered
Table 24. COX-2 Selective NSAIDs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global COX-2 Selective NSAIDs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global COX-2 Selective NSAIDs Sales Market Share Geographic Region (2021-2026)
Table 29. Global COX-2 Selective NSAIDs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global COX-2 Selective NSAIDs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global COX-2 Selective NSAIDs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global COX-2 Selective NSAIDs Sales Market Share by Country/Region (2021-2026)
Table 33. Global COX-2 Selective NSAIDs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global COX-2 Selective NSAIDs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units)
Table 36. Americas COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026)
Table 37. Americas COX-2 Selective NSAIDs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 39. Americas COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 40. APAC COX-2 Selective NSAIDs Sales by Region (2021-2026) & (K Units)
Table 41. APAC COX-2 Selective NSAIDs Sales Market Share by Region (2021-2026)
Table 42. APAC COX-2 Selective NSAIDs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 44. APAC COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 45. Europe COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units)
Table 46. Europe COX-2 Selective NSAIDs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 48. Europe COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa COX-2 Selective NSAIDs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa COX-2 Selective NSAIDs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa COX-2 Selective NSAIDs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa COX-2 Selective NSAIDs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of COX-2 Selective NSAIDs
Table 54. Key Market Challenges & Risks of COX-2 Selective NSAIDs
Table 55. Key Industry Trends of COX-2 Selective NSAIDs
Table 56. COX-2 Selective NSAIDs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. COX-2 Selective NSAIDs Distributors List
Table 59. COX-2 Selective NSAIDs Customer List
Table 60. Global COX-2 Selective NSAIDs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global COX-2 Selective NSAIDs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas COX-2 Selective NSAIDs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC COX-2 Selective NSAIDs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC COX-2 Selective NSAIDs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe COX-2 Selective NSAIDs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa COX-2 Selective NSAIDs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa COX-2 Selective NSAIDs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global COX-2 Selective NSAIDs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global COX-2 Selective NSAIDs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global COX-2 Selective NSAIDs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global COX-2 Selective NSAIDs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 76. Pfizer COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Teva Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 80. Teva COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 81. Teva COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Teva Main Business
Table 83. Teva Latest Developments
Table 84. Mylan Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 85. Mylan COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 86. Mylan COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Mylan Main Business
Table 88. Mylan Latest Developments
Table 89. Apotex Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 90. Apotex COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 91. Apotex COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Apotex Main Business
Table 93. Apotex Latest Developments
Table 94. Lupin Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 95. Lupin COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 96. Lupin COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Lupin Main Business
Table 98. Lupin Latest Developments
Table 99. Jiangsu Hengrui Medicine Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 100. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 101. Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Jiangsu Hengrui Medicine Main Business
Table 103. Jiangsu Hengrui Medicine Latest Developments
Table 104. Merck Basic Information, COX-2 Selective NSAIDs Manufacturing Base, Sales Area and Its Competitors
Table 105. Merck COX-2 Selective NSAIDs Product Portfolios and Specifications
Table 106. Merck COX-2 Selective NSAIDs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. Merck Main Business
Table 108. Merck Latest Developments
LIST OF FIGURES
Figure 1. Picture of COX-2 Selective NSAIDs
Figure 2. COX-2 Selective NSAIDs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COX-2 Selective NSAIDs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global COX-2 Selective NSAIDs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. COX-2 Selective NSAIDs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. COX-2 Selective NSAIDs Sales Market Share by Country/Region (2025)
Figure 10. COX-2 Selective NSAIDs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Celecoxib
Figure 12. Product Picture of Rofecoxib
Figure 13. Product Picture of Valdecoxib
Figure 14. Product Picture of Etoricoxib
Figure 15. Global COX-2 Selective NSAIDs Sales Market Share by Type in 2026
Figure 16. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2026)
Figure 17. COX-2 Selective NSAIDs Consumed in Hospital
Figure 18. Global COX-2 Selective NSAIDs Market: Hospital (2021-2026) & (K Units)
Figure 19. COX-2 Selective NSAIDs Consumed in Clinic
Figure 20. Global COX-2 Selective NSAIDs Market: Clinic (2021-2026) & (K Units)
Figure 21. COX-2 Selective NSAIDs Consumed in Other
Figure 22. Global COX-2 Selective NSAIDs Market: Other (2021-2026) & (K Units)
Figure 23. Global COX-2 Selective NSAIDs Sale Market Share by Application (2025)
Figure 24. Global COX-2 Selective NSAIDs Revenue Market Share by Application in 2026
Figure 25. COX-2 Selective NSAIDs Sales by Company in 2026 (K Units)
Figure 26. Global COX-2 Selective NSAIDs Sales Market Share by Company in 2026
Figure 27. COX-2 Selective NSAIDs Revenue by Company in 2026 ($ millions)
Figure 28. Global COX-2 Selective NSAIDs Revenue Market Share by Company in 2026
Figure 29. Global COX-2 Selective NSAIDs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global COX-2 Selective NSAIDs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 32. Americas COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 33. APAC COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 34. APAC COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 35. Europe COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 36. Europe COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 39. Americas COX-2 Selective NSAIDs Sales Market Share by Country in 2026
Figure 40. Americas COX-2 Selective NSAIDs Revenue Market Share by Country (2021-2026)
Figure 41. Americas COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 42. Americas COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 43. United States COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC COX-2 Selective NSAIDs Sales Market Share by Region in 2026
Figure 48. APAC COX-2 Selective NSAIDs Revenue Market Share by Region (2021-2026)
Figure 49. APAC COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 50. APAC COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 51. China COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 55. India COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe COX-2 Selective NSAIDs Sales Market Share by Country in 2026
Figure 59. Europe COX-2 Selective NSAIDs Revenue Market Share by Country (2021-2026)
Figure 60. Europe COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 61. Europe COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 62. Germany COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 63. France COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 70. Egypt COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of COX-2 Selective NSAIDs in 2026
Figure 76. Manufacturing Process Analysis of COX-2 Selective NSAIDs
Figure 77. Industry Chain Structure of COX-2 Selective NSAIDs
Figure 78. Channels of Distribution
Figure 79. Global COX-2 Selective NSAIDs Sales Market Forecast by Region (2027-2032)
Figure 80. Global COX-2 Selective NSAIDs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global COX-2 Selective NSAIDs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global COX-2 Selective NSAIDs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global COX-2 Selective NSAIDs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global COX-2 Selective NSAIDs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of COX-2 Selective NSAIDs
Figure 2. COX-2 Selective NSAIDs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COX-2 Selective NSAIDs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global COX-2 Selective NSAIDs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. COX-2 Selective NSAIDs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. COX-2 Selective NSAIDs Sales Market Share by Country/Region (2025)
Figure 10. COX-2 Selective NSAIDs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Celecoxib
Figure 12. Product Picture of Rofecoxib
Figure 13. Product Picture of Valdecoxib
Figure 14. Product Picture of Etoricoxib
Figure 15. Global COX-2 Selective NSAIDs Sales Market Share by Type in 2026
Figure 16. Global COX-2 Selective NSAIDs Revenue Market Share by Type (2021-2026)
Figure 17. COX-2 Selective NSAIDs Consumed in Hospital
Figure 18. Global COX-2 Selective NSAIDs Market: Hospital (2021-2026) & (K Units)
Figure 19. COX-2 Selective NSAIDs Consumed in Clinic
Figure 20. Global COX-2 Selective NSAIDs Market: Clinic (2021-2026) & (K Units)
Figure 21. COX-2 Selective NSAIDs Consumed in Other
Figure 22. Global COX-2 Selective NSAIDs Market: Other (2021-2026) & (K Units)
Figure 23. Global COX-2 Selective NSAIDs Sale Market Share by Application (2025)
Figure 24. Global COX-2 Selective NSAIDs Revenue Market Share by Application in 2026
Figure 25. COX-2 Selective NSAIDs Sales by Company in 2026 (K Units)
Figure 26. Global COX-2 Selective NSAIDs Sales Market Share by Company in 2026
Figure 27. COX-2 Selective NSAIDs Revenue by Company in 2026 ($ millions)
Figure 28. Global COX-2 Selective NSAIDs Revenue Market Share by Company in 2026
Figure 29. Global COX-2 Selective NSAIDs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global COX-2 Selective NSAIDs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 32. Americas COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 33. APAC COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 34. APAC COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 35. Europe COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 36. Europe COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa COX-2 Selective NSAIDs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa COX-2 Selective NSAIDs Revenue 2021-2026 ($ millions)
Figure 39. Americas COX-2 Selective NSAIDs Sales Market Share by Country in 2026
Figure 40. Americas COX-2 Selective NSAIDs Revenue Market Share by Country (2021-2026)
Figure 41. Americas COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 42. Americas COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 43. United States COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC COX-2 Selective NSAIDs Sales Market Share by Region in 2026
Figure 48. APAC COX-2 Selective NSAIDs Revenue Market Share by Region (2021-2026)
Figure 49. APAC COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 50. APAC COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 51. China COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 55. India COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe COX-2 Selective NSAIDs Sales Market Share by Country in 2026
Figure 59. Europe COX-2 Selective NSAIDs Revenue Market Share by Country (2021-2026)
Figure 60. Europe COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 61. Europe COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 62. Germany COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 63. France COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa COX-2 Selective NSAIDs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa COX-2 Selective NSAIDs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa COX-2 Selective NSAIDs Sales Market Share by Application (2021-2026)
Figure 70. Egypt COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries COX-2 Selective NSAIDs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of COX-2 Selective NSAIDs in 2026
Figure 76. Manufacturing Process Analysis of COX-2 Selective NSAIDs
Figure 77. Industry Chain Structure of COX-2 Selective NSAIDs
Figure 78. Channels of Distribution
Figure 79. Global COX-2 Selective NSAIDs Sales Market Forecast by Region (2027-2032)
Figure 80. Global COX-2 Selective NSAIDs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global COX-2 Selective NSAIDs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global COX-2 Selective NSAIDs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global COX-2 Selective NSAIDs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global COX-2 Selective NSAIDs Revenue Market Share Forecast by Application (2027-2032)
